Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -5.37%44.6B | -6.53%194.36B | -11.60%59.69B | -11.09%49.18B | -4.86%38.37B | 5.23%47.13B | 27.92%207.94B | 21.84%67.52B | 32.55%55.31B | 31.30%40.33B |
Cost of revenue | -7.17%27.65B | -12.64%120.75B | -17.79%36.66B | -21.68%29.58B | -11.40%24.71B | 6.59%29.79B | 44.03%138.21B | 26.57%44.6B | 53.89%37.77B | 61.01%27.89B |
Gross profit | -2.28%16.95B | 5.57%73.62B | 0.46%23.03B | 11.72%19.59B | 9.82%13.65B | 2.98%17.34B | 4.72%69.73B | 13.58%22.92B | 2.07%17.54B | -7.14%12.43B |
Operating expense | 11.65%14.86B | 2.88%56.17B | 7.25%14.83B | 4.76%14.91B | -2.82%13.12B | 2.09%13.31B | 1.48%54.6B | 1.09%13.83B | 7.71%14.23B | -0.97%13.5B |
Staff costs | ---- | 1.86%13.47B | ---- | ---- | ---- | ---- | 1.00%13.23B | ---- | ---- | ---- |
Selling and administrative expenses | ---- | 7.46%21.67B | ---- | ---- | ---- | ---- | 1.94%20.17B | ---- | ---- | ---- |
-General and administrative expense | ---- | 7.46%21.67B | ---- | ---- | ---- | ---- | 1.94%20.17B | ---- | ---- | ---- |
Depreciation and amortization | ---- | -2.52%11.14B | ---- | ---- | ---- | ---- | -3.01%11.43B | ---- | ---- | ---- |
-Depreciation | ---- | -0.25%10.19B | ---- | ---- | ---- | ---- | -1.71%10.21B | ---- | ---- | ---- |
-Amortization | ---- | -21.51%956M | ---- | ---- | ---- | ---- | -12.69%1.22B | ---- | ---- | ---- |
Other operating expenses | ---- | 1.11%9.88B | ---- | ---- | ---- | ---- | 6.97%9.77B | ---- | ---- | ---- |
Operating profit | -48.24%2.09B | 15.28%17.45B | -9.86%8.2B | 41.70%4.69B | 150.00%534M | 6.02%4.03B | 18.32%15.14B | 39.87%9.09B | -16.70%3.31B | -337.70%-1.07B |
Net non-operating interest income (expenses) | -58.06%-49M | -8.28%-157M | -34.21%-51M | -13.51%-42M | 5.71%-33M | 11.43%-31M | 2.03%-145M | 0.00%-38M | 7.50%-37M | 0.00%-35M |
Non-operating interest income | --0 | 100.00%2M | --1M | --0 | 0.00%1M | --0 | -50.00%1M | --0 | --0 | 0.00%1M |
Non-operating interest expense | 58.06%49M | 8.90%159M | 36.84%52M | 13.51%42M | -5.56%34M | -11.43%31M | -2.67%146M | -2.56%38M | -7.50%37M | 0.00%36M |
Net investment income | -15.38%11M | 23.53%21M | 50.00%-3M | 200.00%6M | -50.00%5M | -31.58%13M | -39.29%17M | 25.00%-6M | -120.69%-6M | 400.00%10M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | -88.77%179M | |||||||
Income from associates and other participating interests | 32.26%41M | 18.18%104M | 2.04%50M | 0 | 109.09%23M | 138.46%31M | 158.82%88M | 276.92%49M | 87.50%15M | 83.33%11M |
Special income (charges) | 161.54%8M | -671.02%-2.42B | -828.98%-2.63B | 1,350.00%200M | 625.00%21M | -18.18%-13M | -982.76%-314M | -4,616.67%-283M | 52.94%-16M | -500.00%-4M |
Less:Restructuring and mergern&acquisition | ---- | --2.42B | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Less:Other special charges | -161.54%-8M | -98.09%6M | -24.38%214M | -1,350.00%-200M | -625.00%-21M | 18.18%13M | 982.76%314M | 4,616.67%283M | -52.94%16M | 500.00%4M |
Other non-operating income (expenses) | 3.92%53M | -18.42%155M | -51.09%45M | -60.00%14M | 40.63%45M | 64.52%51M | 1.06%190M | -14.81%92M | -7.89%35M | 146.15%32M |
Income before tax | -47.27%2.16B | -0.01%15.14B | -38.32%5.6B | 47.47%4.86B | 156.65%596M | 6.91%4.09B | 4.77%15.15B | 31.72%9.08B | -17.24%3.3B | -205.09%-1.05B |
Income tax | -42.13%702M | -5.64%4.32B | -46.19%1.46B | 49.74%1.46B | 170.15%188M | 4.21%1.21B | 2.07%4.58B | 30.06%2.7B | -23.13%977M | -182.21%-268M |
Net income | -49.44%1.45B | 2.43%10.83B | -34.99%4.14B | 46.51%3.4B | 152.04%408M | 8.13%2.87B | 5.99%10.57B | 32.46%6.37B | -14.49%2.32B | -216.32%-784M |
Net income continuous operations | -49.44%1.45B | 2.43%10.83B | -34.98%4.14B | 46.51%3.4B | 152.04%408M | 8.09%2.87B | 5.98%10.57B | 32.44%6.37B | -14.49%2.32B | -216.15%-784M |
Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to the company | -49.44%1.45B | 2.43%10.83B | -34.98%4.14B | 46.51%3.4B | 152.11%408M | 8.13%2.87B | 5.98%10.57B | 32.47%6.37B | -14.49%2.32B | -215.83%-783M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -49.44%1.45B | 2.43%10.83B | -34.98%4.14B | 46.51%3.4B | 152.11%408M | 8.13%2.87B | 5.98%10.57B | 32.47%6.37B | -14.49%2.32B | -215.83%-783M |
Gross dividend payment | ||||||||||
Basic earnings per share | -48.40%13.03 | 3.28%95.64 | -34.22%36.75 | 47.71%30.03 | 153.24%3.61 | 8.93%25.25 | 7.37%92.6 | 34.05%55.87 | -13.42%20.33 | -214.92%-6.78 |
Diluted earnings per share | -48.40%13.03 | 3.28%95.64 | -34.22%36.75 | 47.71%30.03 | 152.44%3.6048 | 8.93%25.25 | 7.37%92.6 | 34.05%55.87 | -13.42%20.33 | -216.98%-6.8739 |
Dividend per share | 0 | 15.38%75 | 15.38%37.5 | 0 | 15.38%37.5 | 0 | 30.00%65 | 30.00%32.5 | 0 | 30.00%32.5 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |